- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Markets
Stocks
F&O
Mutual Funds
- More
Astonea Labs IPO
₹1,28,000/1000 shares
Minimum Investment
IPO Details
27 May 25
29 May 25
₹1,28,000
1000
₹128 to ₹135
BSE
₹37.67 Cr
03 Jun 25
Astonea Labs IPO Timeline
Bidding Start
27 May 25
Bidding Ends
29 May 25
Allotment Finalisation
30 May 25
Refund Initiation
02 Jun 25
Demat Transfer
02 Jun 25
Listing
03 Jun 25
Astonea Labs Limited
Incorporated in 2017, Astonea Labs Ltd. specialises in contract manufacturing of pharmaceutical and cosmetic products for domestic and international clients. Its offerings include antibiotics, anti-cold medicines, antihistamines, and treatments for diabetes, heart, and gynaecological conditions. The company also produces skincare, oral care, and haircare products in various forms such as gels, creams, and serums. In addition to marketing its own brands—Glow Up, Regero, and the upcoming Avicel—Astonea exports to countries like Iraq and Yemen. As of August 16, 2024, it employed 217 people.
Astonea Labs Limited IPO Overview
The Astonea Labs IPO is a book-built issue worth ₹37.67 crores, comprising entirely of a fresh issue of 27.90 lakh equity shares. The IPO will open for public subscription on May 27, 2025, and close on May 29, 2025. The allotment of shares is expected to be finalised on Friday, May 30, 2025, with the tentative listing scheduled for Tuesday, June 3, 2025, on the BSE SME platform.
The price band for the IPO has been set between ₹128 to ₹135 per share. Retail investors are required to apply for a minimum lot size of 1,000 shares, translating to a minimum investment of ₹1,28,000. However, investors are advised to bid at the cut-off price (₹135 per share) to reduce the risk of missing out in case of oversubscription, which brings the investment closer to ₹1,35,000. For High Net-Worth Individuals (HNIs), the minimum application size is 2 lots (2,000 shares), requiring an investment of ₹2,70,000.
Oneview Corporate Advisors Pvt. Ltd. is acting as the book-running lead manager for the IPO, while Kfin Technologies Limited is the appointed registrar for the issue.
Astonea Labs Limited IPO Details
| Particulars | Details |
| IPO Date | 27 May 2025 to 29 May 2025 |
| Listing Date | 3 June 2025 |
| Face Value | ₹10 per share |
| Issue Price Band | ₹128 to ₹135 per share |
| Lot Size | 1000 Shares |
| Total Issue Size | 27,90,000 shares (aggregating up to ₹37.67 Cr) |
| Fresh Issue | 27,90,000 shares (aggregating up to ₹37.67 Cr) |
| Offer for Sale | NA |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 77,21,000 shares |
| Share Holding Post Issue | 1,05,11,000 shares |
| Market Maker Portion | 1,44,000 shares |
Astonea Labs Limited IPO Reservation
| Investor Category | Shares Offered |
| QIB | Not more than 50% of the Net Issue |
| Retail | Not less than 35% of the Net Issue |
| NII (HNI) | Not less than 15% of the Net Issue |
Astonea Labs Limited IPO Lot Size
| Application | Lots | Shares | Amount |
| Retail (Min) | 1 | 1,000 | ₹1,35,000 |
| Retail (Max) | 1 | 1,000 | ₹1,35,000 |
| HNI (Min) | 2 | 2,000 | ₹2,70,000 |
Astonea Labs Limited IPO Promoter Holding
| Shareholding Status | Percentage |
| Pre-Issue | 98.42% |
| Post-Issue | – |
Astonea Labs Limited IPO Valuation Overview
| KPI | Value |
| Earnings Per Share (EPS) | 5.01 |
| Price/Earnings (P/E) Ratio | TBD |
| Return on Net Worth (RoNW) | 31.83% |
| Net Asset Value (NAV) | 15.75 |
| Return on Equity | 37.86% |
| Return on Capital Employed (ROCE) | 22.95% |
| EBITDA Margin | 14.60% |
| PAT Margin | 4.75% |
| Debt to Equity Ratio | 2.16 |
Objectives of the Proceeds
- Funding of expenses for registration in Bolivia, South America – ₹128.97 lakhs
- Purchase and installation of plant and machinery on the 2nd floor of the existing premises at Haripur, Tehsil Raipur Rani, District Panchkula, Haryana, for the ointment plant as per USFDA guidelines (for export purposes) – ₹523.40 lakhs
- Advertising, marketing, and brand building – ₹495.15 lakhs
- Investment in procuring hardware and software – ₹68.38 lakhs
- Funding for working capital requirements – ₹1,975.00 lakhs
- General corporate purposes
Key Financials (in ₹ lakhs)
| Particulars | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 8089.38 | 6427.51 | 5291.8 |
| Revenue | 8019.09 | 6705.08 | 3005.69 |
| Profit After Tax | 510.52 | 108.12 | 57.88 |
| Reserves and Surplus | 436.75 | 415.77 | 349.25 |
| Total Borrowings | 4239.71 | 3598.90 | 2952.49 |
SWOT Analysis of Astonea Labs IPO
Strength and Opportunities
- WHO-GMP, ISO, CE, PETA, HALAL, ECO CERT certified manufacturing.
- Diverse product portfolio: tablets, capsules, softgels, creams, etc.
- Significant daily production capacity across multiple product forms.
- In-house formulation and development capabilities.
- Established presence in both domestic and international markets.
Risks and Threats
- Intense competition in the pharmaceutical and cosmeceutical sectors.
- Regulatory challenges across different international markets.
- Dependence on third-party contracts for a substantial portion of revenue.
- Potential supply chain disruptions affecting raw material availability.
- Rapid technological advancements requiring continuous adaptation.
Explore IPO Opportunities
Explore our comprehensive IPO pages to stay updated on the latest trends and insights.
About Astonea Labs Limited
IPO Strengths
- Astoneabenefits from an experienced management team with over six years in the industry, which has contributed to building a sustainable business and a strong clientele network.
- The company has successfully recruited and retained technically competent employees, recognising that its success relies on the dedication of its human resources.
- Astonea operates on a scalable, customer-centric, and order-driven business model that supports efficient resource use and market expansion.
- The organisation offers a diverse range of pharmaceutical and cosmetic products that meet stringent industry standards.
- Its focus on quality and timely service has strengthened customer loyalty, driving repeat business and enhancing goodwill.
Peer Group Comparison
| Name of the Company | Face Value (₹) | PE | RONW (%) | EPS | NAV (₹) | Total Income (₹ in lakhs) |
| Astonea Labs Limited | 10 | [●] | 31.83% | 5.01 | [●] | 8,028.85 |
| Peer Groups | ||||||
| Beta Drugs Limited | 10 | 37.9 | 49.00% | 23.19 | 163.43 | 29,707.26 |
How to apply IPO with HDFC SKY?
Follow these simple steps to apply for an IPO through HDFC SKY. Secure your investments and explore new opportunities with ease by accessing the IPOs available on the platform.
1Login to your HDFC SKY Account
2Select Issue
3Enter Number of Lots and your Price.
4Enter UPI ID
5Complete Transaction on Your UPI App
FAQs On Astonea Labs Limited IPO
How can I apply for Astonea Labs Limited IPO?
You can apply via HDFCSky, or other brokers using UPI-based ASBA (Application Supported by Blocked Amount).
When is the Astonea Labs IPO open for subscription?
The IPO opens on 27 May 2025 and closes on 29 May 2025 for public subscription.
What is the price band for the Astonea Labs IPO?
The price band is set between ₹128 to ₹135 per equity share
What is the minimum investment required for retail investors?
Retail investors must invest in one lot of 1,000 shares, totalling ₹1,35,000.
Where will the Astonea Labs shares be listed?
The shares will be listed on the BSE SME platform on 3 June 2025.
By signing up I certify terms, conditions & privacy policy